Efficacy of Two Prophylactic Schedules (Prulifloxacin Versus Phosphomycin)
Launched by UNIVERSITY OF PERUGIA · Oct 29, 2010
Trial Information
Current as of June 09, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients
- • Age over 18 years old
- • No allergies to the drugs to be prescribed
- • No counter-indications to this drug therapy
- • Urine culture shows responsiveness to drugs at recruitment of patient
- • History of urinary tract infections with at least three episodes in the previous year or two in the past six months
- Exclusion Criteria:
- • Lack of tolerability of prescribed drugs
About University Of Perugia
The University of Perugia, a prestigious academic institution located in Italy, is dedicated to advancing medical research and clinical innovation through its robust clinical trial initiatives. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university aims to contribute to the development of novel therapeutic strategies and improve patient outcomes. Leveraging its extensive network of healthcare professionals and cutting-edge facilities, the University of Perugia fosters a dynamic research environment that supports both local and international clinical studies, ultimately enhancing the quality of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Elisabetta Costantini
Study Chair
University Of Perugia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials